{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:49:41Z","timestamp":1780588181959,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.transci.2013.05.022","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T19:01:49Z","timestamp":1371322909000},"page":"31-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Experience with B-cell lymphoma at a South African centre in the HIV Era"],"prefix":"10.1016","volume":"49","author":[{"given":"Alan","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2013.05.022_b0005","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"On behalf of the FAB LMB96 International study committee. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.05.022_b0010","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.05.022_b0015","first-page":"950","article-title":"The evolving management of Burkitt\u2019s lymphoma at Red Cross Children\u2019s Hospital","volume":"96","author":"Davidson","year":"2006","journal-title":"S Afr Med J"},{"key":"10.1016\/j.transci.2013.05.022_b0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1200\/JCO.2006.06.6506","article-title":"Cancer rates after year 2000 significantly decrease in children with perinatal HIV infection: a study by the Italian register for HIV infection in children","volume":"25","author":"Chiappini","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.05.022_b0025","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/adc.2005.087544","article-title":"Childhood cancer in Ireland: a population-based study","volume":"92","author":"Stack","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.transci.2013.05.022_b0030","unstructured":"Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. (editors). SEER Cancer Statistics Review, 1975\u20132004, National Cancer Institute. Bethesda, MD, <http:\/\/www.seer.cancer.gov\/csr\/1975_2004\/>, based on November 2006 SEER data submission, posted to the SEER web site; 2007 [accessed 27.09.12]."},{"key":"10.1016\/j.transci.2013.05.022_b0035","first-page":"1","article-title":"US HIV and AIDS cases reported through December 1996","volume":"8","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"HIV\/AIDS Surveill Rep"},{"key":"10.1016\/j.transci.2013.05.022_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/jama.284.2.205","article-title":"Risk of cancer in children with AIDS","volume":"284","author":"Biggar","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2013.05.022_b0045","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.1998.16.5.1729","article-title":"Cancer in human immunodeficiency virus-infected children: a case series from the Children\u2019s Cancer Group and the National Cancer Institute","volume":"16","author":"Granovsky","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.05.022_b0050","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1200\/JCO.2000.18.22.3854","article-title":"Human immunodeficiency virus-related cancer in children: Incidence and treatment outcome \u2013 report of the Italian register","volume":"18","author":"Caselli","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.05.022_b0055","first-page":"719","article-title":"Malignancy in HIV-positive South African Children","volume":"53","author":"Davidson","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2013.05.022_b0060","first-page":"778","article-title":"Treatment options for HIV-positive children with B-cell lymphomas","volume":"55","author":"Davidson","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2013.05.022_b0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pbc.21753","volume":"52","author":"Griffin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2013.05.022_b0070","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1200\/JCO.2009.26.6791","article-title":"Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin\u2019s lymphoma and Burkitt leukemia","volume":"28","author":"Meinhardt","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.05.022_b0075","doi-asserted-by":"crossref","first-page":"S9536","DOI":"10.1200\/jco.2010.28.15_suppl.9536","article-title":"Safety, pharmacokinetics (PK) and outcome following Rituximab (R) in combination with FAB chemotherapy in children and adolescents (C+A) with Stage III\/IV (Group B) and BM+\/CNS+ (Group C) mature B-NHL: a Children\u2019s Oncology Group Report","volume":"28","author":"Cairo","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.05.022_b0080","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.05.022_b0085","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1200\/JCO.1993.11.6.1024","article-title":"Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin\u2019s lymphoma: a report of CCG-551 from the Children\u2019s Cancer Group","volume":"11","author":"Anderson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.05.022_b0090","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/pbc.22940","article-title":"European Inter-Group for Childhood, Non-Hodgkin Lymphoma (EICNHL). Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial","volume":"56","author":"Wrobel","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2013.05.022_b0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2559.2005.02175.x","article-title":"Large B-cell lymphoma with Hodgkin\u2019s features","volume":"47","author":"Garcia","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.transci.2013.05.022_b0100","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin\u2019s lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Path"},{"key":"10.1016\/j.transci.2013.05.022_b0105","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2141.2011.09024.x","article-title":"Risk factors and treatment of childhood and adolescent Burkitt lymphoma\/leukaemia","volume":"156","author":"Miles","year":"2012","journal-title":"Br J Haem"},{"key":"10.1016\/j.transci.2013.05.022_b0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/pbc.20917","article-title":"Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998\u20132003","volume":"48","author":"Sinfield","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2013.05.022_b0115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/adc.76.4.330","article-title":"Malignancies in UK children with HIV infection acquired from mother to child transmission","volume":"76","author":"Evans","year":"1997","journal-title":"Arch Dis Child"},{"issue":"8","key":"10.1016\/j.transci.2013.05.022_b0120","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active anti-retroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.05.022_b0125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.tripleo.2005.03.028","volume":"100","author":"Radhakrishnan","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.transci.2013.05.022_b0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00008480-199602000-00010","article-title":"Malignancies in pediatric AIDS","volume":"8","author":"Mueller","year":"1998","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.transci.2013.05.022_b0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0971-5851.68854","article-title":"Lymphoma in HIV patients: varied presentations","volume":"31","author":"Saple","year":"2010","journal-title":"Ind J Med Pediatr Oncol"},{"key":"10.1016\/j.transci.2013.05.022_b0140","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2004-05-1747","article-title":"Protease inhibitors potentiate chemotherapy-induced neutropenia","volume":"104","author":"Bower","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.05.022_b0145","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma in combination with highly active anti-retroviral therapy","volume":"19","author":"Ratner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.05.022_b0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B","article-title":"Concomitant cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy plus highly active anti-retroviral in patients with immunodeficiency virus-related, non-Hodgkin lymphoma","volume":"91","author":"Vaccher","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2013.05.022_b0155","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose adjusted EPOCH: impact of antiretroviral therapy suspension and tumour biology","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.05.022_b0160","doi-asserted-by":"crossref","unstructured":"Vishnu P, Aboulafia DM. AIDS-related Non-Hodgkin\u2019s Lymphoma in the Era of Highly active Antiretroviral Therapy. Adv Hematol 2012: Epub 6 Feb.","DOI":"10.1155\/2012\/485943"},{"key":"10.1016\/j.transci.2013.05.022_b0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOP.0b013e3282f424b0","article-title":"The efficacy of rituximab in high-grade pediatric B-cell lymphoma\/leukaemia: a review of available evidence","volume":"20","author":"Attias","year":"2008","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.transci.2013.05.022_b0170","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.05.022_b0175","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diff use large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.transci.2013.05.022_b0180","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood.V90.8.2921","article-title":"High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt\u2019s lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry","volume":"90","author":"Ladenstein","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.05.022_b0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pbc.20121","article-title":"Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group","volume":"44","author":"Attarbaschi","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2013.05.022_b0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbmt.2010.07.002","article-title":"Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children\u2019s Oncology Group study A5962","volume":"17","author":"Harris","year":"2011","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2013.05.022_b0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbmt.2009.09.021","article-title":"Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents","volume":"16","author":"Gross","year":"2010","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305021300181X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305021300181X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T14:12:18Z","timestamp":1595945538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305021300181X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S147305021300181X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2013.05.022","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience with B-cell lymphoma at a South African centre in the HIV Era","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2013.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}